MedPath

Testing an individualised digital decision assist system for the diagnosis and management of mental and behavior disorders in children and adolescents

Not Applicable
Conditions
Child and adolescent mental health health disorders
Mental and Behavioural Disorders
Registration Number
ISRCTN12094788
Lead Sponsor
orges forskningsråd
Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32943029/ protocol (added 21/09/2020) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/33384621/ Article (added 16/02/2022) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33068753/ Editorial (added 16/02/2022) 2017 Other publications in https://doi.org/10.36959/447/335 Review article (added 16/02/2022) 2017 Other publications in https://pubmed.ncbi.nlm.nih.gov/28455596/ Systematic review (added 16/02/2022) 2021 Abstract results in https://www.jaacap.org/article/S0890-8567(21)01753-6/fulltext (added 21/02/2022) 2021 Other publications in https://www.dagensmedisin.no/artikler/2021/05/05/kan-datadrevet-kunnskapsstotte-gi-bedre-bup-tjenester/ article in Dagens medisin (added 21/02/2022) 2022 Other publications in https://doi.org/10.1176/appi.ps.202100477 patient awareness, attitudes, and opinions about EHR data storage and sharing (added 16/03/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
30
Inclusion Criteria

Child and adolescent psychologists and psychiatrists working in CAMHS

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Other
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Utility of the IDDEAS CDSS for diagnosis and treatment of child is measured by reviewing the participant’s clinical diagnosis and treatment plan responses as a measure of sensitivity and specificity with the use of the CDSS compared to without the CDSS upon completion of the non-live evaluation and the live evaluation
Secondary Outcome Measures
NameTimeMethod
<br> 1. Perceived clinical usability of the CDSS is measured using the system usability scale (SUS) directly following the evaluation (within 24 hours)<br> 2. Perceived clinical relevance and validity of the system’s user-interface content is measured using the content validity index (CVI) directly following the evaluation (within 24 hours)<br> 3. Perceived appropriateness of the CDSS is measured using the User-Engagement Scale (UES) directly following the evaluation (within 24 hours)<br>
© Copyright 2025. All Rights Reserved by MedPath